Purpose: To explore the safety and feasibility of robot-assisted orbital fat decompression surgery.

Methods: Ten prospectively enrolled patients (18 eyes) with Graves’ ophthalmopathy underwent robot-assisted orbital fat decompression surgery with the da Vinci Xi surgical system. Intraoperative blood loss, operative time, and complications were recorded. For every patient, the exophthalmos of the operated eyes and Graves’ orbitopathy quality of life (GO-QoL) were measured both preoperatively and 3 months postoperatively to assess the surgical effect.

Results: All surgical procedures were successfully performed. The mean duration to complete the whole procedure was 124.3 ± 33.2 minutes (range, 60–188). The mean intraoperative blood loss was 17.8 ± 6.2 mL (range, 7.5–28). There were neither complications nor unexpected events in terms of either orbital decompression surgery or robot-assisted procedures. The mean exophthalmos was 20.2 ± 1.8 mm before surgery and 17.9 ± 1.4 mm postoperatively (P < 0.0001). The preoperative and postoperative GO-QoL on the visual function arm was 84.38 ± 20.04 and 93.75 ± 9.32, respectively. The preoperative and postoperative GO-QoL on the appearance arm was 42.50 ± 14.97 and 64.38 ± 21.46, respectively (P = 0.027).

Conclusions: The da Vinci Xi surgical system provided the stability, dexterity, and good visualization necessary for orbital fat decompression surgery, indicating the safety and feasibility of robot-assisted orbital fat decompression surgery.

Translational Relevance: Based on a literature search using EMBASE and MEDLINE databases, we believe that this study reports the first in-human results of the safety and effectiveness of da Vinci robot-assisted orbital fat decompression surgery.

目的：探讨机器人辅助眼眶脂肪减压手术的安全性和可行性。

方法：10 名前瞻性入组的 Graves 眼病患者（18 只眼）接受了机器人辅助的 da Vinci Xi 手术系统眼眶脂肪减压手术。记录术中失血量、手术时间和并发症。对于每位患者，在术前和术后 3 个月测量手术眼的眼球突出和 Graves 眼眶病生活质量（GO-QoL），以评估手术效果。

结果：所有外科手术均顺利进行。完成整个过程的平均持续时间为 124.3 ± 33.2 分钟（范围，60-188）。平均术中失血量为 17.8 ± 6.2 mL（范围，7.5-28）。无论是眼眶减压手术还是机器人辅助手术，都没有出现并发症或意外事件。术前平均突眼为 20.2 ± 1.8 mm，术后为 17.9 ± 1.4 mm（P < 0.0001）。视觉功能组的术前和术后 GO-QoL 分别为 84.38 ± 20.04 和 93.75 ± 9.32。外观组术前术后GO-QoL分别为42.50±14.97和64.38±21.46（P =0.027）。

结论：da Vinci Xi手术系统提供了眼眶脂肪减压手术所需的稳定性、灵巧性和良好的可视性，表明机器人辅助眼眶脂肪减压手术的安全性和可行性。

转化相关性：基于使用 EMBASE 和 MEDLINE 数据库的文献检索，我们认为本研究报告了达芬奇机器人辅助眼眶脂肪减压手术的安全性和有效性的第一个人体结果。